Antiretroviral Resistance patterns in HIV-1 infected patients failing to second-line in Bamako, Mali

被引:0
|
作者
Maiga, A. I. [1 ]
Traore, F. T. [2 ,3 ]
Dolo, O. [2 ]
Togo, J. [2 ]
Calvez, V. [4 ]
Katlama, C. [5 ]
Marcelin, A-G [4 ]
机构
[1] Univ Sci Tech & Technol Bamako, Bamako, Mali
[2] Univ Sci Tech & Technol Bamako, Ctr Rech & Format VIH & TB SEREFO, Bamako, Mali
[3] CHU Gabriel Toure, Dept Biol Med, Bamako, Mali
[4] Hop La Pitie Salpetriere, Serv Virol, Paris, France
[5] Hop La Pitie Salpetriere, Serv Malad Infect & Trop, Paris, France
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
PE13/34
引用
收藏
页码:175 / 176
页数:2
相关论文
共 50 条
  • [21] HIV-1 drug resistance and third-line outcomes among children and adolescents failing second-line therapy in Malawi
    Lee, L.
    Mbingwani, I.
    Kalua, T.
    Spiers, S.
    Duranti, S.
    Schramm, B.
    Kamba, R.
    Szumilin, E.
    Salumu, L.
    Maman, D.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 : 83 - 83
  • [22] Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda
    Ssebambulidde, Kenneth
    Segawa, Ivan
    Laker, Eva
    Lamorde, Mohammed
    Castelnouvo, Barbara
    Nakasujja, Noeline
    Calcagno, Andrea
    OXFORD MEDICAL CASE REPORTS, 2019, (02): : 79 - 82
  • [23] Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART
    Saracino, Annalisa
    Gianotti, Nicola
    Marangi, Marianna
    Cibelli, Donatella C.
    Galli, Andrea
    Punzi, Grazia
    Monno, Laura
    Lazzarin, Adriano
    Angarano, Gioacchino
    JOURNAL OF MEDICAL VIROLOGY, 2008, 80 (10) : 1695 - 1706
  • [24] Efficacy of first and second-line antiretroviral therapies in HIV-1 infected children, a case-control study in Cambodia
    Barennes, H.
    Kang, V.
    Rouet, F.
    Buisson, Y.
    Vibol, U.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 172 - 172
  • [25] Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa
    Fox, Matthew P.
    Berhanu, Rebecca
    Steegen, Kim
    Firnhaber, Cindy
    Ive, Prudence
    Spencer, David
    Mashamaite, Sello
    Sheik, Sadiyya
    Jonker, Ingrid
    Howell, Pauline
    Long, Lawrence
    Evans, Denise
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2016, 21 (09) : 1131 - 1137
  • [26] Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individuals
    Simon, V
    Vanderhoeven, J
    Hurley, A
    Ramratnam, B
    Louie, M
    Dawson, K
    Parkin, N
    Boden, D
    Markowitz, M
    AIDS, 2002, 16 (11) : 1511 - 1519
  • [27] Second-Line Antiretroviral Treatment Outcome in HIV-Infected Patients Coinfected with Tuberculosis in Pakistan
    Shafiq, Muhammad
    Zafar, Sana
    Ahmad, Aftab
    Kazmi, Abeer
    Fatima, Alina
    Mujahid, Tanvir Ahmed
    Qazi, Rizwan
    Akhter, Nasim
    Shahzad, Amir
    Rehman, Saif Ur
    Shereen, Muhammad Adnan
    Hyder, Muhammad Zeeshan
    BIOMED RESEARCH INTERNATIONAL, 2023, 2023
  • [28] Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
    Ciaffi, Laura
    Koulla-Shiro, Sinata
    Sawadogo, Adrien
    le Moing, Vincent
    Eymard-Duvernay, Sabrina
    Izard, Susanne
    Kouanfack, Charles
    Gueye, Ndeye Fatou Ngom
    Fobang, Avelin Aghokeng
    Reynes, Jacques
    Calmy, Alexandra
    Delaporte, Eric
    AIDS, 2015, 29 (12) : 1473 - 1481
  • [29] Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia
    Getaneh, Yimam
    He, Qianxin
    Rashid, Abdur
    Kassa, Desta
    Kang, Li
    Yi, Feng
    Liao, Lingjie
    Shao, Yiming
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 30 : 418 - 427
  • [30] Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
    Adetayo Emmanuel Obasa
    Anoop T. Ambikan
    Soham Gupta
    Ujjwal Neogi
    Graeme Brendon Jacobs
    BMC Infectious Diseases, 21